BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 21895853)

  • 1. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
    Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
    J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Clin Chem Lab Med; 2010 Oct; 48(10):1467-73. PubMed ID: 20604722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
    Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
    Groblewska M; Mroczko B; Kozlowski M; Niklinski J; Laudanski J; Szmitkowski M
    Folia Histochem Cytobiol; 2012; 50(4):590-8. PubMed ID: 23264224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
    Chen CG; Cui L; Tang P; Yu ZT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Pol Arch Med Wewn; 2009 Sep; 119(9):558-63. PubMed ID: 19776700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.
    Kosugi S; Nishimaki T; Kanda T; Nakagawa S; Ohashi M; Hatakeyama K
    World J Surg; 2004 Jul; 28(7):680-5. PubMed ID: 15383868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
    Shimada Y; Watanabe G; Kawamura J; Soma T; Okabe M; Ito T; Inoue H; Kondo M; Mori Y; Tanaka E; Imamura M
    Oncology; 2005; 68(2-3):285-92. PubMed ID: 16015046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
    BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
    Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
    Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
    Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
    J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
    Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma.
    Zhao H; Chen W; Wu J; Wang L; Mao W
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C179-85. PubMed ID: 25450279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.